Syngene International appoints Cipla’s Sanjay Nandavadekar as AVP-IT

Syngene International, a subsidiary of the biopharmaceutical major Biocon, has appointed Sanjay Nandavadekar as Associate Vice President of Information Technology (IT) and Head of IT for Discovery Services. He will lead the IT function and contribute to the organization's digital strategy. Before joining Syngene International, Nandavadekar was the Senior Director of IT at pharmaceutical company Cipla. 

With over 25 years of experience, including 17 years in the pharmaceutical industry, Nandavadekar has a proven track record in crafting digital strategies, developing scalable infrastructure, and aligning IT with business objectives. His leadership and technology skills have helped organizations gain a competitive edge through automation, efficiency improvements, process optimisation, and digital leadership. 

He has also demonstrated expertise in managing large enterprise projects focused on process improvement, cost leadership, compliance, and ROI. His core areas of proficiency include business relations with vendors and staying up-to-date with the latest technology trends, including artificial intelligence (AI), internet of things (IoT), robotic process automation (RPA), Chatbot, natural language processing (NLP), and business intelligence (BI).  

Nandavadekar, who is a computer engineer and has done an executive management programme from Indian Institute of Management Ahmedabad (IIM-A) has successfully implemented cutting-edge technologies like Industry 4.0 and has experience managing high-volume budgets, according to his LinkedIn profile. 

The company has recently outlined an annual investment plan that exceed $100 million with a primary focus on research, biologics, and small molecules going forward.  

Additionally, it has made a cumulative investment of approximately Rs 4,500 crores. Out of this total, about 50% has been allocated to research activities, nearly 30% dedicated to small molecules, and the remaining portion utilised for large molecules, IT, digitisation, and other needs, it said.